1-Chloro-N,N,2-trimethyl-1-propenylamine - CAS 26189-59-3
Catalog: |
BB019179 |
Product Name: |
1-Chloro-N,N,2-trimethyl-1-propenylamine |
CAS: |
26189-59-3 |
Synonyms: |
1-chloro-N,N,2-trimethylprop-1-en-1-amine |
IUPAC Name: | 1-chloro-N,N,2-trimethylprop-1-en-1-amine |
Description: | 1-Chloro-N,N-2-trimethylpropenylamine (>90%) acts as a reagent in the synthesis and antitumor activity of (-)-bassianolide in human cancer cells through cell cycle arrest. Enantioselective total synthesis of nannocystins A and A0 as elongation factor 1 inhibitors. Total synthesis of (-)-caprazamycin A with antibacterial activity against Mycobacterium tuberculosis (TB) via diastereoselective aldol reaction. |
Molecular Weight: | 133.62 |
Molecular Formula: | C6H12ClN |
Canonical SMILES: | CC(=C(N(C)C)Cl)C |
InChI: | InChI=1S/C6H12ClN/c1-5(2)6(7)8(3)4/h1-4H3 |
InChI Key: | GQIRIWDEZSKOCN-UHFFFAOYSA-N |
Boiling Point: | 129-130 °C |
Purity: | 95 % |
Density: | 1.01 g/cm3 |
Appearance: | Colorless to yellow liquid |
Storage: | Freezer (-20 °C) |
MDL: | MFCD00800562 |
LogP: | 2.03820 |
GHS Hazard Statement: | H226 (100%): Flammable liquid and vapor [Warning Flammable liquids] |
Precautionary Statement: | P210, P233, P240, P241, P242, P243, P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P370+P378, P403+P235, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113150192-A | Chiral helix-loaded aromatic amide type resin and preparation method and application thereof | 20210430 |
WO-2021202977-A1 | Pyrrolopyrimidine amines as complement inhibitors | 20200403 |
US-2021317135-A1 | Rip1k inhibitors | 20200402 |
WO-2021203011-A1 | Rip1k inhibitors | 20200402 |
US-2021238188-A1 | Heterocyclic compounds as anti-viral agents | 20200124 |
PMID | Publication Date | Title | Journal |
11801189 | 20010101 | NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272 | BMC pharmacology |
Complexity: | 101 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 133.0658271 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 133.0658271 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 3.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.7 |
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB030539
(±)-2,3-Dibromobutane
Detail
-
Catalog: BB030086
(1-Bromoethyl)benzene
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB078191
((3-Bromobenzyl)oxy)(tert-butyl)dimethylsilane
Detail
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS